Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Sales | 82,654 | 0 | 0 | 0 |
| Gross Profit | 82,654 | N/A | N/A | N/A |
| Operating Expenses | 138,450 | 84,048 | 0 | 0 |
| Operating Income | -55,796 | -84,048 | N/A | N/A |
| Other Income | 3,384 | 8,743 | 0 | 0 |
| Pre-tax Income | -52,412 | -75,305 | 0 | 0 |
| Net Income Continuous | -52,412 | -75,305 | N/A | N/A |
| Net Income | $-52,412 | $-75,305 | $N/A | $N/A |
| EPS Basic Total Ops | -5.40 | -21.82 | N/A | N/A |
| EPS Basic Continuous Ops | -1.23 | -21.82 | N/A | N/A |
| EPS Diluted Total Ops | -5.40 | -21.82 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.23 | -21.82 | N/A | N/A |
| EBITDA(a) | $-52,663 | $-83,698 | $N/A | $N/A |